LIF and neoplasm: The combination treatment of chemotherapy, anti-LIF, and anti-PD-L1 led to an increase in M1 macrophages and a reduction in M2 macrophages, accompanied by enhanced interferon response pathways, suggesting a shift towards an anti-tumor phenotype.